pillbase.ru

CAPRELSA

Active substance: vandetanib

TABLET, FILM COATED · VANDETANIB 300 mg/1

United StatesActive

Marketing holder: Genzyme Corporation

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 2
  • Caprelsa
    vandetanib
    EMEA/H/C/002315
    Esteve Pharmaceuticals, S.A.
  • Zactima
    vandetanib
    EMEA/H/C/001194
    AstraZeneca
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208d-4c98-70e7-bcba-2ee1e95e3f6d,01a12098-db10-78d5-809c-ce77c5c25e2c;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
58468-7840
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 58468-7840 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 58468-7840 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 58468-7840 · Verified 2026-10-09 · open in source